These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 29488193)

  • 1. Influence of Formulation Factors on the Aerosol Performance and Stability of Lysozyme Powders: a Systematic Approach.
    Ferrati S; Wu T; Fuentes O; Brunaugh AD; Kanapuram SR; Smyth HDC
    AAPS PharmSciTech; 2018 Oct; 19(7):2755-2766. PubMed ID: 29488193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders.
    Brunaugh AD; Wu T; Kanapuram SR; Smyth HDC
    Mol Pharm; 2019 Oct; 16(10):4165-4180. PubMed ID: 31448924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of excipients on the stability and aerosol performance of salmon calcitonin dry powder inhalers prepared via the spray freeze drying process.
    Poursina N; Vatanara A; Rouini MR; Gilani K; Najafabadi AR
    Acta Pharm; 2016 Jun; 66(2):207-18. PubMed ID: 27279064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry-powder formulations of non-covalent protein complexes with linear or miktoarm copolymers for pulmonary delivery.
    Nieto-Orellana A; Coghlan D; Rothery M; Falcone FH; Bosquillon C; Childerhouse N; Mantovani G; Stolnik S
    Int J Pharm; 2018 Apr; 540(1-2):78-88. PubMed ID: 29425761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Budesonide Particles for Dry Powder Inhalation Prepared Using a Microfluidic Reactor Coupled With Ultrasonic Spray Freeze Drying.
    Saboti D; Maver U; Chan HK; Planinšek O
    J Pharm Sci; 2017 Jul; 106(7):1881-1888. PubMed ID: 28285981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle engineering of materials for oral inhalation by dry powder inhalers. I-Particles of sugar excipients (trehalose and raffinose) for protein delivery.
    Ogáin ON; Li J; Tajber L; Corrigan OI; Healy AM
    Int J Pharm; 2011 Feb; 405(1-2):23-35. PubMed ID: 21129458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation.
    Yu H; Teo J; Chew JW; Hadinoto K
    Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of formulation and inhaler parameters on the dispersion of spray freeze dried voriconazole particles.
    Liao Q; Lam ICH; Lin HHS; Wan LTL; Lo JCK; Tai W; Kwok PCL; Lam JKW
    Int J Pharm; 2020 Jun; 584():119444. PubMed ID: 32445908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.
    Aquino RP; Prota L; Auriemma G; Santoro A; Mencherini T; Colombo G; Russo P
    Int J Pharm; 2012 Apr; 426(1-2):100-107. PubMed ID: 22301426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
    Li X; Vogt FG; Hayes D; Mansour HM
    Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Carrier Free Dry Powder Inhalation Formulation of Ketotifen for Pulmonary Drug Delivery.
    Azari F; Ghanbarzadeh S; Safdari R; Yaqoubi S; Adibkia K; Hamishehkar H
    Drug Res (Stuttg); 2020 Jan; 70(1):26-32. PubMed ID: 31533157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry powders for inhalation containing monoclonal antibodies made by thin-film freeze-drying.
    Hufnagel S; Xu H; Sahakijpijarn S; Moon C; Chow LQM; Williams Iii RO; Cui Z
    Int J Pharm; 2022 Apr; 618():121637. PubMed ID: 35259440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation.
    Fabio K; Curley K; Guarneri J; Adamo B; Laurenzi B; Grant M; Offord R; Kraft K; Leone-Bay A
    AAPS PharmSciTech; 2015 Dec; 16(6):1299-306. PubMed ID: 25776985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large porous particles for respiratory drug delivery. Glycine-based formulations.
    Ogienko AG; Bogdanova EG; Trofimov NA; Myz SA; Ogienko AA; Kolesov BA; Yunoshev AS; Zubikov NV; Manakov AY; Boldyrev VV; Boldyreva EV
    Eur J Pharm Sci; 2017 Dec; 110():148-156. PubMed ID: 28479348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of Inhalable Dry Powder Formulations Loaded with Nanoparticles Maintaining Their Original Physical Properties and Functions].
    Okuda T
    Yakugaku Zasshi; 2017; 137(11):1339-1348. PubMed ID: 29093369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient optimization of high-dose formulation of novel lyophilizates for dry powder inhalation by the combination of response surface methodology and time-of-flight measurement.
    Ohori R; Kiuchi S; Sugiyama S; Miyamoto K; Akita T; Yamashita C
    Int J Pharm; 2020 May; 581():119255. PubMed ID: 32217154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach.
    Karimi K; Pallagi E; Szabó-Révész P; Csóka I; Ambrus R
    Drug Des Devel Ther; 2016; 10():3331-3343. PubMed ID: 27784991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of excipient enhanced growth (EEG) tobramycin dry powder aerosol formulations.
    Hassan A; Farkas D; Longest W; Hindle M
    Int J Pharm; 2020 Dec; 591():120027. PubMed ID: 33130220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein inhalation powders: spray drying vs spray freeze drying.
    Maa YF; Nguyen PA; Sweeney T; Shire SJ; Hsu CC
    Pharm Res; 1999 Feb; 16(2):249-54. PubMed ID: 10100310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.